Angiotensin receptor-neprilysin inhibitor for the treatment of heart failure: a review of recent evidence
Author:
Publisher
Korean Association of Internal Medicine
Link
http://kjim.org/upload/kjim-2020-105.pdf
Reference62 articles.
1. Epidemiology of Heart Failure in Korea: Present and Future
2. Update on heart failure management and future directions
3. Long-Term Trends in the Incidence of and Survival with Heart Failure
4. Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
5. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Irreversible myocardial injury attenuates the benefits of sacubitril/valsartan in heart failure patients;International Journal of Cardiology;2024-02
2. Optimization of guideline-directed medical treatment for heart failure patients with reduced ejection fraction;The Korean Journal of Internal Medicine;2023-09-01
3. Obesity-related heart failure with preserved ejection fraction: diagnostic and therapeutic challenges;The Korean Journal of Internal Medicine;2023-03-01
4. Predicting hospital readmissions in patients receiving novel-dose Sacubitril/Valsartan therapy: A competing-risk, causal mediation analysis;2023-02-10
5. Neferine ameliorates hypertensive vascular remodeling modulating multiple signaling pathways in spontaneously hypertensive rats;Biomedicine & Pharmacotherapy;2023-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3